Overview

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Status:
Completed

Trial end date:
2017-03-17

Target enrollment:

Participant gender:

Summary

To explore the efficacy and safety of four BAY1003803 formulations by means of a within subject comparison in an open Psoriasis Plaque Test

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Calcipotriene
Calcitriol
Clobetasol